Interaction of metabolic and haemodynamic factors in mediating experimental diabetic nephropathy

Cited by (377)

Items 101–200 of 377

1. The Potential of Albuminuria as a Biomarker of Diabetic Complications
   Pappitha Raja, Alexander Peter Maxwell, Derek P. Brazil · 2020 · Cardiovascular Drugs and Therapy
2. T2DiACoD: A Gene Atlas of Type 2 Diabetes Mellitus Associated Complex Disorders
   Jyoti Rani, Inna Mittal, Atreyi Pramanik, Namita Singh, Namita Dube, Smriti Sharma, Bhanwar Lal Puniya, Muthukurussi Varieth Raghunandanan, Ahmed Mobeen, Srinivasan Ramachandran · 2017 · Scientific Reports
3. Fetal Exposure to Maternal Type 1 Diabetes Is Associated With Renal Dysfunction at Adult Age
   Charbel Abi Khalil, Florence Travert, Lila-Sabrina Fetita, François Rouzet, Raphaël Porcher, Jean‐Pierre Riveline, Samy Hadjadj, Étienne Larger, Ronan Roussel, Patrick Vexiau et al. · 2010 · Diabetes
4. Evidence for renoprotection by blockade of the renin–angiotensin–aldosterone system in hypertension and diabetes
   Janaka J. Karalliedde, Gian Carlo Viberti · 2006 · Journal of Human Hypertension
5. Deficiency of cannabinoid receptor of type 2 worsens renal functional and structural abnormalities in streptozotocin-induced diabetic mice
   Federica Barutta, Séréna Grimaldi, Irene Franco, Stefania Bellini, Roberto Gambino, Silvia Pinach, Alessandro Corbelli, Graziella Bruno, Maria Pia Rastaldi, Teresa Aveta et al. · 2014 · Kidney International
6. The protective effect of Salvia miltiorrhiza in an animal model of early experimentally induced diabetic nephropathy
   Sang‐Hun Lee, Young-Seok Kim, Seung‐Jin Lee, Byung-Cheol Lee · 2011 · Journal of Ethnopharmacology
7. MicroRNA in Diabetic Nephropathy: Renin Angiotensin, AGE/RAGE, and Oxidative Stress Pathway
   Shinji Hagiwara, Aaron McClelland, Phillip Kantharidis · 2013 · Journal of Diabetes Research
8. Vasopeptidase inhibition prevents nephropathy in Zucker diabetic fatty rats
   S SCHAFER · 2003 · Cardiovascular Research
9. Diabetic nephropathy: A potential savior with ‘rotten-egg’ smell
   George Johnson Dugbartey · 2016 · Pharmacological Reports
10. RETRACTED: Taraxerol, a pentacyclic triterpenoid, from Abroma augusta leaf attenuates diabetic nephropathy in type 2 diabetic rats
    Ritu Khanra, Niloy Bhattacharjee, Tarun Kumar Dua, Ashis Kumar Nandy, Achintya Saha, Jatin Kalita, Prasenjit Manna, Saikat Dewanjee · 2017 · Biomedicine & Pharmacotherapy · Retracted
11. Fractalkine and Its Receptor, CX3CR1, Upregulation in Streptozotocin-Induced Diabetic Kidneys
    Yuichi Kikuchi, Ryota Ikee, Noriaki Hemmi, Naomi Hyodo, Takamitsu Saigusa, Tamehachi Namikoshi, Muneharu Yamada, Shigenobu Suzuki, Soichiro Miura · 2004 · Nephron Experimental Nephrology
12. Pigment epithelium-derived factor (PEDF) inhibits proximal tubular cell injury in early diabetic nephropathy by suppressing advanced glycation end products (AGEs)-receptor (RAGE) axis
    Sayaka Maeda, Takanori Matsui, Masayoshi Takeuchi, Yumiko Yoshida, Ryoji Yamakawa, Kei Fukami, Sho‐ichi Yamagishi · 2010 · Pharmacological Research
13. Targeting the protein kinase C family in the diabetic kidney: lessons from analysis of mutant mice
    Matthias Meier, Jan Menne, Hermann G. Haller · 2009 · Diabetologia
14. Could Systemic Inflammatory Index Predict Diabetic Kidney Injury in Type 2 Diabetes Mellitus?
    Tuba Taslamacıoğlu Duman, Buse Balci, Feyza Nihal Ozkul · 2023 · Diagnostics
15. Mizoribine reduces renal injury and macrophage infiltration in non-insulin-dependent diabetic rats
    Yuichi Kikuchi, Toshihiko Imakiire, Muneharu Yamada, Takamitsu Saigusa, Toshitake Hyodo, Naomi Hyodo, Shigenobu Suzuki, Soichiro Miura · 2005 · Nephrology Dialysis Transplantation
16. Pathogenesis of Diabetic Nephropathy
    Claudia M.A. Van Dijk, Tomás Berl · 2004 · Reviews in Endocrine and Metabolic Disorders
17. Effects of NADPH oxidase inhibitor on diabetic nephropathy in OLETF rats: The role of reducing oxidative stress in its protective property
    Soo Min Nam, Eun Young Lee, Jang Hyun Koh, Jun Ho Park, Jang Yel Shin, Young Goo Shin, Sang Baek Koh, Eun Young Lee, Choon Hee Chung · 2008 · Diabetes Research and Clinical Practice
18. RAGE Mediates Accelerated Diabetic Vein Graft Atherosclerosis Induced by Combined Mechanical Stress and AGEs via Synergistic ERK Activation
    Yuhuang Li, Shuying Liu, Zhengyu Zhang, Qingbo Xu, Fukang Xie, Jingjing Wang, Suning Ping, Chen Li, 汪照静, Min Zhang et al. · 2012 · PLoS ONE
19. Beneficial effects of metformin and irbesartan on advanced glycation end products (AGEs)–RAGE-induced proximal tubular cell injury
    Yuji Ishibashi, Takanori Matsui, Masayoshi Takeuchi, Sho‐ichi Yamagishi · 2011 · Pharmacological Research
20. Wnt5a promotes renal tubular inflammation in diabetic nephropathy by binding to CD146 through noncanonical Wnt signaling
    Xiaomei Li, Jiejun Wen, Yang Dong, Qunzi Zhang, Jian Guan, Feng Liu, Ting Zhou, Ze Li, Ying Fan, Niansong Wang · 2021 · Cell Death and Disease
21. Dynamic blood pressure load and nephropathy in the ZSF1 (fa/facp) model of type 2 diabetes
    Karen A. Griffin, Mohammad Abu-Naser, Isam Abu‐Amarah, Maria Mrozowicz Picken, Geoffrey A. Williamson, ANIL K. BIDANI · 2007 · American Journal of Physiology-Renal Physiology
22. The mechanisms underlying altered vascular resistance of glomerular afferent and efferent arterioles in diabetic nephropathy
    Shuji Arima · 2003 · Nephrology Dialysis Transplantation
23. Ergosterol ameliorates renal inflammatory responses in mice model of diabetic nephropathy
    Chunyan Liu, Shuling Zhao, Chunjing Zhu, Qian Gao, Jing Bai, Jie Si, Yunxia Chen · 2020 · Biomedicine & Pharmacotherapy
24. Identification of fibronectin 1 (FN1) and complement component 3 (C3) as immune infiltration-related biomarkers for diabetic nephropathy using integrated bioinformatic analysis
    Yuejun Wang, Mingming Zhao, Yu Zhang · 2021 · Bioengineered
25. Clinical implication of plasma and urine YKL-40, as a proinflammatory biomarker, on early stage of nephropathy in type 2 diabetic patients
    Jun Ho Lee, Sang Soo Kim, In Joo Kim, Sang Heon Song, Yong Ki Kim, Ju In Kim, Yun Kyung Jeon, Bo Hyun Kim, Ihm Soo Kwak · 2012 · Journal of Diabetes and its Complications
26. Potential Contributory Role of H-Ras, a Small G-Protein, in the Development of Retinopathy in Diabetic Rats
    Renu A. Kowluru, Anjaneyulu Kowluru, Subrata Chakrabarti, Zia Ali Khan · 2004 · Diabetes
27. Diabetic renal disease: from recent studies to improved clinical practice
    Carl Erik Mogensen, Mark E. Cooper · 2004 · Diabetic Medicine
28. Receptor for advanced glycation endproducts and progressive kidney disease
    Fukami, Kei, Taguchi, Kensei, Yamagishi, Sho-ichi, Okuda, Seiya · 2015 · Current Opinion in Nephrology and Hypertension
29. Nephroprotective effect of Paeonia emodi via inhibition of advanced glycation end products and oxidative stress in streptozotocin–nicotinamide induced diabetic nephropathy
    Lalit Kishore, Navpreet Kaur, Randhir Singh · 2016 · Journal of Food and Drug Analysis
30. New insights into the significance of microalbuminuria
    Richard J. MacIsaac, George Jerums, Mark Emmanuel Cooper · 2003 · Current Opinion in Nephrology & Hypertension
31. Blood Pressure Lowering for the Prevention and Treatment of Diabetic Kidney Disease
    Merlin C. Thomas, Robert C. Atkins · 2006 · Drugs
32. Lowering of Proteinuria in Response to Antihypertensive Therapy Predicts Improved Renal Function in Late but Not in Early Diabetic Nephropathy: A Pooled Analysis
    George Jerums, Sianna Panagiotopoulos, Erosha Premaratne, David A. Power, Richard J. MacIsaac · 2008 · American Journal of Nephrology
33. Tributyltin chloride induces renal dysfunction by inflammation and oxidative stress in female rats
    João Victor da Silva Coutinho, Leandro Ceotto Freitas‐Lima, Frederico Felipe Costa Tebas de Freitas, Flávia Freitas, Priscila L. Podratz, Rafaella Papalino Lopes Magnago, Marcella L. Porto, Silvana S. Meyrelles, Elisardo C. Vasquez, Poliane A.A. Brandão et al. · 2016 · Toxicology Letters
34. Tea Polypeptide Ameliorates Diabetic Nephropathy through RAGE and NF-κB Signaling Pathway in Type 2 Diabetes Mice
    Xuming Deng, Lingli Sun, Xingfei Lai, Limin Xiang, Qiuhua Li, Wenji Zhang, Lingzhi Zhang, Shili Sun · 2018 · Journal of Agricultural and Food Chemistry
35. New insights into the importance of aminopeptidase A in hypertension
    Shigehiko Mizutani, Masakazu Ishii, Akira Hattori, Seiji Nomura, Yasushi Numaguchi, Masafumi Tsujimoto, Hiroshi Kobayshi, Toyoaki Murohara, John W. Wright · 2007 · Heart Failure Reviews
36. Altered gap junctional communication and renal haemodynamics in Zucker fatty rat model of type 2 diabetes
    Tsuneo Takenaka, Tsutomu Inoue, Hirokazu Okada, Yoichi Ohno, Takashi Miyazaki, Daniel J. Chaston, Caryl Elizabeth Hill, Hiromichi Suzuki · 2011 · Diabetologia
37. Novel therapeutic approaches for diabetic nephropathy and retinopathy
    Vera Usuelli, Ennio La Rocca · 2014 · Pharmacological Research
38. Aortic Stiffness as a Surrogate Endpoint to Micro- and Macrovascular Complications in Patients with Type 2 Diabetes
    Claudia R.L. Cardoso, Gil Fernando Salles · 2016 · International Journal of Molecular Sciences
39. Renal accumulation and clearance of advanced glycation end-products in type 2 diabetic nephropathy: effect of angiotensin-converting enzyme and vasopeptidase inhibition
    Cornelia Wihler, Stefan Schäfer, Karoline Schmid, Elizabeth K. Deemer, Gerald W Münch, Markus Bleich, Andreas E Busch, Theo Dingermann, Veronika Somoza, John Baynes et al. · 2005 · Diabetologia
40. Effects of the combination of an angiotensin II antagonist with an HMG-CoA reductase inhibitor in experimental diabetes
    Qin, Jie, Zhang, Zhili, Liu, Jie, Sun, Liao, Hu, Ling, Cooper, Mark E., Cao, Zemin · 2003 · Kidney International
41. Effects of Heat-Processed Ginseng and Its Active Component Ginsenoside 20(S)-Rg3 on the Progression of Renal Damage and Dysfunction in Type 2 Diabetic Otsuka Long-Evans Tokushima Fatty Rats
    Ki Sung Kang, Noriko Yamabe, Hyun Young Kim, Jeong Hill Park, Takako Yokozawa · 2010 · Biological and Pharmaceutical Bulletin
42. Epidermal Growth Factor Receptor: A Potential Therapeutic Target for Diabetic Kidney Disease
    Lili Sheng, George P Bayliss, Shougang Zhuang · 2021 · Frontiers in Pharmacology
43. Diabetic nephropathy: What does the future hold?
    Rosa Montero, Adrian Constantin Covic, Luigi Gnudi, David J.A. Goldsmith · 2015 · International Urology and Nephrology
44. Haemodynamics in microvascular complications in type 1 diabetes
    Riccardo Candido, Terri J. Allen · 2002 · Diabetes/Metabolism Research and Reviews
45. ACE inhibitor reduces growth factor receptor expression and signaling but also albuminuria through B2-kinin glomerular receptor activation in diabetic rats
    Julien Allard, Marie Buléon, Éric Cellier, Isabelle M. Renaud, Christiane Pécher, Françoise Praddaude, Marc Conti, Ivan Tack, Jean‐Pierre Girolami · 2007 · American Journal of Physiology-Renal Physiology
46. The CREB/KMT5A complex regulates PTP1B to modulate high glucose-induced endothelial inflammatory factor levels in diabetic nephropathy
    Ting Huang, Xue Li, Fei Wang, Lihong Lu, Wenting Hou, Minmin Zhu, Changhong Miao · 2021 · Cell Death and Disease
47. Relationship between pigment epithelium-derived factor (PEDF) and renal function in patients with diabetic retinopathy.
    Kayako Matsuyama, Nahoko Ogata, Masato Matsuoka, Chieko Shima, Mitsumasa Wada, Nobuo Jo, Miyo Matsumura · 2008 · PubMed Central
48. Losartan and other angiotensin II antagonists for nephropathy in type 2 diabetes mellitus: A review of the clinical trial evidence
    Luis Miguel Ruilope, J. Segura · 2003 · Clinical Therapeutics
49. Renoprotective effects of Caraway (Carum carvi L.) essential oil in streptozotocin induced diabetic rats
    Neveen Helmy Abou El-Soud, Nabila A. El-Laithy, Gamila El-Saeed, Mohamed Salah Wahby, Mona Y. Khalil, Fatma Morsy, Nermeen Shaffie · 2014 · Journal of Applied Pharmaceutical Science
50. Treatment effects of renin-angiotensin aldosterone system blockade on kidney failure and mortality in chronic kidney disease patients
    Phisitt Vejakama, Atiporn Ingsathit, Gareth J. McKay, Alexander Peter Maxwell, Mark McEvoy, John Attia, Ammarin Thakkinstian · 2017 · BMC Nephrology
51. IL-20 in Acute Kidney Injury: Role in Pathogenesis and Potential as a Therapeutic Target
    Tian-Yu Lin, Yu‐Hsiang Hsu · 2020 · International Journal of Molecular Sciences
52. A New Perspective on Therapeutic Inhibition of Advanced Glycation in Diabetic Microvascular Complications: Common Downstream Endpoints Achieved Through Disparate Therapeutic Approaches?
    Karly C. Sourris, Brooke E. Harcourt, Josephine Maree Forbes · 2009 · American Journal of Nephrology
53. Preventing end stage renal disease in diabetic patients — genetic aspect (part I)
    Peter Karl Jacobsen · 2005 · Journal of the Renin-Angiotensin-Aldosterone System
54. The pathophysiologic basis for blocking the renin-angiotensin system in hypertensive patients with renal disease
    Leopoldo R. Raij · 2005 · American Journal of Hypertension
55. The vasopeptidase inhibitor AVE7688 ameliorates Type 2 diabetic nephropathy
    S. G. Sch�fer, Wolfgang Linz, Henning Vollert, Gabriele Biemer‐Daub, H. R�tten, Markus Bleich, Andreas E Busch · 2004 · Diabetologia
56. Nifedipine inhibits advanced glycation end products (AGEs) and their receptor (RAGE) interaction-mediated proximal tubular cell injury via peroxisome proliferator-activated receptor-gamma activation
    Takanori Matsui, Sho‐ichi Yamagishi, Masayoshi Takeuchi, Seiji Ueda, Kei Fukami, Seiya Okuda · 2010 · Biochemical and Biophysical Research Communications
57. Tempol reduces oxidative stress and restores renal dopamine D1-like receptor- G protein coupling and function in hyperglycemic rats
    Aditi Marwaha, Mustafa F. Lokhandwala · 2006 · American Journal of Physiology-Renal Physiology
58. Effect of 2-dodecyl-6-methoxycyclohexa-2,5-diene-1,4-dione, isolated from Averrhoa carambola L. (Oxalidaceae) roots, on advanced glycation end-product-mediated renal injury in type 2 diabetic KKAy mice
    Ni Zheng, Xing Lin, Qingwei Wen, Kintoko, Shijun Zhang, Jianchun Huang, Xiaohui Xu, Renbin Huang · 2013 · Toxicology Letters · Retracted
59. Protein kinase C beta inhibitors: a new therapeutic target for diabetic nephropathy and vascular complications
    S Budhiraja, J Singh · 2008 · Fundamental and Clinical Pharmacology
60. Poly(ADP-ribose) polymerase (PARP) inhibition counteracts multiple manifestations of kidney disease in long-term streptozotocin-diabetic rat model
    Hanna Shevalye, Roman Stavniichuk, Weizheng Xu, Jie Zhang, Sergey Lupachyk, Yury Maksimchyk, Viktor R. Drel, Z. Elizabeth Floyd, Barbara Stauch Slusher, Irina G. Obrosova · 2009 · Biochemical Pharmacology
61. Pathogenesis and Novel Treatment from the Mouse Model of Type 2 Diabetic Nephropathy
    Masako Furukawa, Tomohito Gohda, Mitsuo Tanimoto, Yasuhiko Tomino · 2013 · The Scientific World JOURNAL
62. Metformin suppresses LRG1 and TGFβ1/ALK1-induced angiogenesis and protects against ultrastructural changes in rat diabetic nephropathy
    Hala M.F. Mohammad, Sahar Galal Gouda, Mohamed Ahmed Eladl, Amany Y. Elkazaz, Khaled S. El-Bayoumi, Noha E. Farag, Amr Aly Elshormilisy, Buthainah B. Alammash, Ann Hegazy, Sozan M. Abdelkhalig et al. · 2022 · Biomedicine & Pharmacotherapy
63. Beneficial effects of C36, a novel breaker of advanced glycation endproducts cross‐links, on the cardiovascular system of diabetic rats
    Gang Cheng, L‐L Wang, L Long, H‐Y Liu, Hao Zhen Cui, W‐S Qu, S. Li · 2007 · British Journal of Pharmacology
64. Nuclear Factor-.KAPPA.B Activation in Diabetic Rat Kidney: Evidence for Involvement of P-Selectin in Diabetic Nephropathy
    Masateru Iwamoto, Sonoo Mizuiri, Michitsune Arita, Hiromichi Hemmi · 2005 · The Tohoku Journal of Experimental Medicine
65. Urinary markers of renal inflammation in adolescents with Type 1 diabetes mellitus and normoalbuminuria
    David Z.I. Cherney, J. W. Scholey, Denis Daneman, David B. Dunger, R. Neil Dalton, Rahim Moineddin, Farid H. Mahmud, R. Dekker, Yesmino T. Elia, Etienne B. Sochett et al. · 2012 · Diabetic Medicine
66. Molecular Insights into the Relationship Between Platelet Activation and Endothelial Dysfunction: Molecular Approaches and Clinical Practice
    Niloufar Kazemi, Armin Bordbar, Samaneh Salehipour Bavarsad, Parisa Ghasemi, Maryam Bakhshi, Hadi Rezaeeyan · 2024 · Molecular Biotechnology
67. Thymoquinone protects renal tubular cells against tubular injury
    Ahmed Amir Radwan Sayed · 2008 · Cell Biochemistry and Function
68. Comparison of the Effects of Korean Ginseng and Heat-Processed Korean Ginseng on Diabetic Oxidative Stress
    Hyun Young Kim, Ki Sung Kang, Noriko Yamabe, Takako Yokozawa · 2008 · The American Journal of Chinese Medicine
69. Therapeutic effect of Linum usitatissimum L. in STZ-nicotinamide induced diabetic nephropathy via inhibition of AGE’s and oxidative stress
    Navpreet Kaur, Lalit Kishore, Randhir Singh · 2017 · Journal of Food Science and Technology
70. Bioactive Agent Discovery from the Natural Compounds for the Treatment of Type 2 Diabetes Rat Model
    Shih-Chun Yang, Ching‐Yun Hsu, Wei-Ling Chou, Jia‐You Fang, Shih-Yi Chuang · 2020 · Molecules
71. Calcium channel blockers, either amlodipine or mibefradil, ameliorate renal injury in experimental diabetes
    Guorong Ma, Terri J. Allen, Mark Emmanuel Cooper, Zemin Cao · 2004 · Kidney International
72. Deletion of protein tyrosine phosphatase SHP-1 restores SUMOylation of podocin and reverses the progression of diabetic kidney disease
    Farah Lizotte, Marina Rousseau, Benoît Denhez, Dominique Lévesque, Andréanne Guay, Hongbo Liu, Julie Moreau, Sarah Higgins, Robert Sabbagh, Katalin Suszták et al. · 2023 · Kidney International
73. Advanced glycation end‐product‐induced mitogenesis and collagen production are dependent on angiotensin II and connective tissue growth factor in NRK‐49F cells
    Chu‐I Lee, Jinn‐Yuh Guh, Hung‐Chun Chen, Wen‐Chun Hung, Yu‐Lin Yang, Lea‐Yea Chuang · 2005 · Journal of Cellular Biochemistry
74. Below the radar: advanced glycation end products that detour "around the side". Is HbA1c not an accurate enough predictor of long term progression and glycaemic control in diabetes?
    Josephine Maree Forbes, Georgia Soldatos, Merlin C. Thomas · 2005 · Europe PMC (PubMed Central)
75. Race-Specific Differences in Antioxidant Enzyme Activity in Patients With Type 2 Diabetes
    Karima Zitouni, Jaffar Nourooz‐Zadeh, D. S. Harry, Sally Kerry, D. J. Betteridge, Francesco Paolo Cappuccio, Kenneth Earle · 2005 · Diabetes Care
76. Potential Targeting of Renal Fibrosis in Diabetic Kidney Disease Using MicroRNAs
    Hiroko Sakuma, Shinji Hagiwara, Phillip Kantharidis, Tomohito Gohda, Yusuke Suzuki · 2020 · Frontiers in Pharmacology
77. Nailing down PKC isoform specificity in diabetic nephropathy two's company, three's a crowd
    Matthias Meier, J. Menne, J.-K. Park, Hermann G. Haller · 2007 · Nephrology Dialysis Transplantation
78. A Network Pharmacology Approach to Uncover the Mechanisms of Shen‐Qi‐Di‐Huang Decoction against Diabetic Nephropathy
    Sha Di, Lin Han, Qing Wang, Xinkui Liu, Yingying Yang, Fan Li, Linhua Zhao, Xiaolin Tong · 2018 · Evidence-based Complementary and Alternative Medicine
79. Complications of Diabetes Mellitus
    Michael Brownlee, Lloyd Paul Aiello, Mark Emmanuel Cooper, Aaron I. Vinik, Jorge Plutzky, Andrew J.M. Boulton · 2016 · Elsevier eBooks
80. Network pharmacology combined with metabolomics to study the mechanism of Shenyan Kangfu Tablets in the treatment of diabetic nephropathy
    Xiaoli Wang, Qiaoyu He, Qian Chen, Beibei Xue, Jia Wang, Tao Wang, Hong Shu Liu, Xiaopeng Chen · 2021 · Journal of Ethnopharmacology
81. The roles of sodium-glucose cotransporter 2 inhibitors in preventing kidney injury in diabetes
    Krit Jaikumkao, Anchalee Pongchaidecha, Varanuj Chatsudthipong, Siriporn Chaisin Chattipakorn, Nipon Chattipakorn, Anusorn Lungkaphin · 2017 · Biomedicine & Pharmacotherapy
82. Elucidating mechanisms underlying altered renal autoregulation in diabetes
    Tsuneo Takenaka, Tsutomu Inoue, Yoichi Ohno, Takashi Miyazaki, Akira Nishiyama, Naohito Ishii, Hiromichi Suzuki · 2012 · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology
83. Comparison of the effects of levocetirizine and losartan on diabetic nephropathy and vascular dysfunction in streptozotocin-induced diabetic rats
    Hanan S. Anbar, George S.G. Shehatou, Ghada Mohamed Suddek, Nariman M. Gameil · 2016 · European Journal of Pharmacology
84. Effects of astragalosides from Radix Astragali on high glucose-induced proliferation and extracellular matrix accumulation in glomerular mesangial cells
    XIAO CHEN, Dongdong Wang, TONG WEI, Su‐Mei He, GUAN-YING ZHANG, Qunli Wei · 2016 · Experimental and Therapeutic Medicine
85. The NCEP‐ATPIII but not the IDF criteria for the metabolic syndrome identify Type 2 diabetic patients at increased risk of chronic kidney disease
    Andrea O. Y. Luk, R. C. W. Ma, WY So, X‐L. Yang, Alice P.S. Kong, Risa Ozaki, Gary T.C. Ko, C‐C. Chow, Clive Stewart Cockram, Juliana C.N. Chan et al. · 2008 · Diabetic Medicine
86. Effect of High Glucose on Superoxide in Human Mesangial Cells: Role of Angiotensin II
    David J. Leehey, Majd A. Isreb, Sonja M. Marcic, Ashok K. Singh, Rekha Singh · 2005 · Nephron Experimental Nephrology
87. Effects of Zishentongluo in Patients with Early-Stage Diabetic Nephropathy
    Jian-wei Ma, Limei Xu, Jing Dong, Hanlin Wei, Yan Zhi, Xinyin Ma, Wenlong Zhang · 2013 · The American Journal of Chinese Medicine
88. Increased Urinary TGF-β1 and Cortical Renal GLUT1 and GLUT2 Levels: Additive Effects of Hypertension and Diabetes
    Beatriz D'Agord Schaan, Maria Cláudia Irigoyen, Marcello Casaccia Bertoluci, Nelson Gianni de Lima, Juliana Passaglia, Eduardo Hermes, Fábio Ramos Oliveira, Maristela Mitiko Okamoto, Ubiratan Fabres Machado · 2005 · Nephron Physiology
89. Diltiazem Attenuates Oxidative Stress in Diabetic Rats
    Muragundla Anjaneyulu, Kanwaljit Chopra · 2005 · Renal Failure
90. α1B-Adrenoceptors mediate adrenergically-induced renal vasoconstrictions in rats with renal impairment
    Abdul H. Khan, Munavvar Zubaid Abdul Sattar, N. Azizan Abdullah, Edward James Johns · 2008 · Acta Pharmacologica Sinica
91. Weighted gene co-expression network analysis identifies FCER1G as a key gene associated with diabetic kidney disease
    Shanshan Liu, Cuili Wang, Huiying Yang, Tingting Zhu, Hong Jiang, Jianghua Chen · 2020 · Annals of Translational Medicine
92. Agents in development for the treatment of diabetic nephropathy
    Su‐Yen Goh, Mariusz Jasik, Mark Emmanuel Cooper · 2008 · Expert Opinion on Emerging Drugs
93. Embelia ribes extract reduces high fat diet and low dose streptozotocin-induced diabetic nephrotoxicity in rats
    Hemantkumar Somabhai Chaudhari, Uma Bhandari, Geetika Khanna · 2013 · EXCLI journal
94. Outcome studies in diabetic nephropathy
    Anupama Mohanram, Robert D. Toto · 2003 · Seminars in Nephrology
95. Vascular endothelial growth factor receptor-2 and low affinity VEGF binding sites on human glomerular endothelial cells: Biological effects and advanced glycosilation end products modulation
    Laura Pala, Barbara Cresci, Cinzia Manuelli, Enrico Maggi, Yoko Yamaguchi, Pietro Cappugi, Carlo Maria Rotella, Stefano Giannini · 2005 · Microvascular Research
96. Highly elevated serum phyto‐oestrogen concentrations in patients with diabetic nephropathy
    Leena von Hertzen, Carol M. Forsblom, Katariina Stumpf, Kim Pettersson-Fernholm, Herman Adlercreutz, Per‐Henrik Groop, on behalf of the FinnDiane Study Group · 2004 · Journal of Internal Medicine
97. Renoprotection by Telmisartan versus Benazepril in Streptozotocin Induced Diabetic Nephropathy
    Janardhan Singh, S Budhiraja, Harbans Lal, B. Arora · 2006 · TSpace (University of Toronto)
98. Preservation of Kidney Function with Combined Inhibition of NADPH Oxidase and Angiotensin-Converting Enzyme in Diabetic Nephropathy
    Vicki Thallas‐Bonke, Melinda T. Coughlan, Leon A. Bach, Mark Emmanuel Cooper, Josephine Maree Forbes · 2010 · American Journal of Nephrology
99. Clusterin/Apolipoprotein J Attenuates Angiotensin II-Induced Renal Fibrosis
    Gwon‐Soo Jung, Jae‐Han Jeon, Yuna Jung, Yeon‐Kyung Choi, Hye‐Soon Kim, Jung‐Guk Kim, Keun‐Gyu Park, Mi Kyung Kim, In‐Kyu Lee · 2014 · PLoS ONE
100. The reno-protective role of AT1-receptor blockers
     Carl Erik Mogensen · 2002 · Journal of Human Hypertension